Impact of pharmacovigilance on adverse drug reactions reporting in hospitalized internal medicine patients at saudi arabian teaching hospital

Saudi Medical Journal

Volumn 33, Issue 8, 2012, Pages 863-868

  Khan Dr , Lateef M ^a   Al Harthi, Sameer E ^a   Saadah, Omar I ^a   Al Amoudi, Ahmed B ^a   Sulaiman, Mansour I ^a   Ibrahim, Ibrahim M ^a  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; ANTINEOPLASTIC AGENT; CARDIOVASCULAR AGENT; DIURETIC AGENT; GLUCOCORTICOID; IMMUNOMODULATING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; DIABETES MELLITUS; DRUG SURVEILLANCE PROGRAM; EPILEPSY; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; PROSPECTIVE STUDY; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; SAUDI ARABIA; SKIN APPENDAGE DISEASE; TEACHING HOSPITAL; UNSPECIFIED SIDE EFFECT; CHEMICALLY INDUCED; DRUG ERUPTIONS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; GASTROINTESTINAL DISEASES; INTERNAL MEDICINE; MIDDLE AGED; POLYPHARMACY; RESPIRATORY TRACT DISEASES; RISK MANAGEMENT; SEX RATIO; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARDIOVASCULAR AGENTS; DIURETICS; DRUG ERUPTIONS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; GASTROINTESTINAL DISEASES; GLUCOCORTICOIDS; HOSPITALS, TEACHING; HUMANS; INCIDENCE; INTERNAL MEDICINE; MALE; MIDDLE AGED; PHARMACOVIGILANCE; POLYPHARMACY; PROSPECTIVE STUDIES; RESPIRATORY TRACT DISEASES; RETROSPECTIVE STUDIES; RISK MANAGEMENT; SAUDI ARABIA; SEX DISTRIBUTION; YOUNG ADULT;

EID: 84867254154     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Gholami K, Shalviri G. Factors associated with preventability, predictability, and severity of adverse drug reactions. Ann Pharmacother 1999; 33: 236-240.
2. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200-1205.
3. Wiffen P, Gill M, Edwards J, Moore A. Adverse drug reactions in hospital patients. Bandolier Extra 2002; 1-15.
4. Davies EC, Green CF, Mottram DR, Pirmohamed M. Adverse drug reactions in hospital in-patients: a pilot study. J Clin Pharm Ther 2006; 31: 335-341.
5. Vora MB, Trivedi HR, Shah BK, Tripathi CB. Adverse drug reactions in inpatients of internal medicine wards at a tertiary care hospital: A prospective cohort study. J Pharmacol Pharmacother 2011; 2: 21-25.
6. Mehta U, Durrheim DN, Blockman M, Kredo T, Gounden R, Barnes KI. Adverse drug reactions in adult medical inpatients in a South African hospital serving a community with a high HIV/AIDS prevalence: prospective observational study. Br J Clin Pharmacol 2008; 65: 396-406.
7. Pourseyed S, Fattahi F, Pourpak Z, Gholami K, Shariatpanahi SS, Moin A, et al. Adverse drug reactions in patients in an Iranian department of internal medicine. Pharmacoepidemiol Drug Saf2009; 18: 104-110.
8. Waller PC, Evans SJ. A model for the future conduct of pharmacovigilance. Pharmacoepidemiol Drug Saf 2003; 12: 17-29.
9. Montastruc JL, Sommet A, Lacroix I, Olivier P, Durrieu G, Damase-Michel C, et al. Pharmacovigilance for evaluating adverse drug reactions: value, organization, and methods. Joint Bone Spine 2006; 73: 629-632.
10. Avery AJ, Anderson C, Bond CM, Fortnum H, Gifford A, Hannaford PC, et al. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys. Health Technol Assess 2011; 15: 1-234.
11. Chien JY, Ho RJ. Drug delivery trends in clinical trials and translational medicine: Evaluation of pharmacokinetic properties in special populations. J Pharm Sci 2011; 100: 5358.
12. Dikshit R. K. Challenges in Pharmacovigilance. Indian Journal ofPharmacol 2010; 42: 333.
13. Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf 2006; 29: 385-396.
14. Wasserfallen J, Livio F, Buclin T, Tillet L, Yersin B, Biollaz J. Rate, type, and cost of adverse drug reactions in emergency department admissions. Eur J Intern Med 2001; 12: 442-447.
15. Routledge PA, O'Mahony MS, Woodhouse KW. Adverse drug reactionsin elderly patients. Br J Clin Pharmacol 2003; 57: 121-126.
16. Wu WK, Pantaleo N. Evaluation of outpatient adverse drug reactions leading to hospitalization. Am J Health Syst Pharm 2003; 60: 253-259.
17. Al-Malaq HM, Al-Aqeel Sa, Al-Sultan MS. Adverse drug reactions related hospitalization identified by discharge ICD-9 codes in a university hospital in Riyadh. Saudi MedJ 2008; 29: 1145-1150.
18. Al-Jazairi AS, Al-Agil AA, Asiri YA, Al-Kholi TA, Akhras NS, Horanieh BK. The impact of clinical pharmacist in a cardiac- surgery intensive care unit. Saudi Med J 2008; 29: 277-281.
19. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-245.
20. Eliasson E. Ethnicity and adverse drug reactions. Br Med J 2006; 332:1163-1164.
21. Camargo AL, Cardoso Ferreira MB, Heineck I. Adverse drug reactions: a cohort study in internal medicine units at a university hospital. Eur J Clin Pharmacol 2006; 62: 143-149.
22. Demoly P, Bousquet J. Epidemiology of drug allergy. Curr Opin Allergy Clin Immunol 2001; 1: 305-310.
23. Kaushal R, Shojania KG, Bates DW. Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review. Arch Intern Med 2003; 163: 1409-1416.
24. Passarelli MC, Jacob-Filho W, Figueras A. Adverse drug reactions in an elderly hospitalized population: inappropriate prescription is a leading cause. Drugs Aging 2005; 22: 767-77.
25. Field TS, Gilman BH, Subramanian S, Fuller JC, Bates DW, Gurwitz JH. The costs associated with adverse drug events among older adults in the ambulatory setting. Med Care 2005; 43: 1171-1176.
26. Gurwitz JH, Field TS, Judge J, Rochon P, Harrold LR, Cadoret C, et al. The incidence of adverse drug events in two large academic long-term care facilities. Am J Med 2005; 118: 251258.
27. Rothschild JM, Bates DW, Leape LL. Preventable medical injuries in older patients. Arch Intern Med 2000; 160: 27172718.
28. Lagnaoui R, Moore N, Fach J, Mongy-Boursier M, Begaud B. Adverse drug reactions in a department of systemic diseases- oriented internal medicine: prevalence, incidence, direct costs and avoidability. Eur J Clin Pharmacol 2000; 55: 181-186.
29. Bordet R, Gautier S, Le Louet H, Dupuis B, Caron J. Analysis of the direct costs of adverse drug reactions in hospitalized patients. Eur J Clin Pharmacol 2001; 56: 935-941.
30. Kanjanarat P, Winterstein AG, Johns TE, Hatton RC, Rothi RG, Segal R. Nature of preventable adverse drug events in hospitals: A literature review. Am J Health-Syst Pharm 2003; 60: 1750-1759.
31. Lundkvist J, Jonsson B. Pharmacoeconomics of adverse drug reactions. Fundam Clin Pharmacol 2004; 18: 275-280.
32. Polimeni G, Salvo F, Cutroneo P, Morreale I, Patrizio Caputi A. Adverse reactions induced by NSAIDs and antibacterials. Drug Safety 2006; 29: 449-459.
33. Shin YS, Lee YW, Choi YH, Park B, Jee YK, Choi SK, et al. Spontaneous reporting of adverse drug events by Korean Regional Pharmacovigilance Centers. Pharmacoepidemiol Drug Saf 2009; 18: 910-915.
34. Suh DC, Woodall BS, Shin SK, Hermes-De-Santis ER. Clinical and economic impact of adverse drug reactions in hospitalized patients. Ann Pharmacotherapy 2000; 34: 1373-1379.
35. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, systematic analysis of population health data. Lancet 2006; 367: 1747-1757.
36. Ramesh M, Pandit J, Parthasarathi G. Adverse drug reactions in a South Indian hospital-their severity and cost involved. Pharmacoepidemiol Drug Saf 2003; 12: 687-692.
37. Franceschi M, Scarcelli C, Niro V, Seripa D, Pazienza AM, Pepe G, et al. Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patients. Drug Saf 2008; 31: 545556.
38. Davies EC, Green CF, Mottram DR, Pirmohamed M. Adverse drug reactions in hospitals: a narrative review. Curr Drug Saf 2007; 2: 79-87.
39. Bachot N, Roujeau JC. Differential diagnosis of severe cutaneous drug eruptions. Am J Clin Dermatol 2003; 4: 561-572.
40. Son YM, Lee JR, Roh JY. Causality assessment of cutaneous adverse drug reactions. Ann Dermatol2011; 23: 432-438.
41. Thong BY, Leong KP, Tang CY, Chng HH. Drug allergy in a general hospital: results of a novel prospective inpatient reporting system. Ann Allergy Asthma Immunol 2003; 90: 342347.
42. Sushma M, Noel MV, Ritika MC, James J, Guido S. Cutaneous adverse drug reactions: a 9-year study from a South Indian Hospital. Pharmacoepidemiol Drug Saf 2005; 14: 567-570